Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003070176A3 Modified defensins and their use
11/27/2003WO2003070157A3 Vitamin d upregulated protein 1 (vdup-1) methods and uses thereof
11/27/2003WO2003068940A3 Complexes and methods of using same
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003066807A9 Method of inhibiting pathogenicity of infectious agents
11/27/2003WO2003064676A3 Diagnostic and therapeutic methods using the h37 tumor suppressor gene
11/27/2003WO2003062268A3 Corticotropin releasing factor receptor 2 agonists
11/27/2003WO2003061590A3 Peptide constructs for treating disease
11/27/2003WO2003059942A9 Peptides and peptidomimetics having anti-proliferative activity and their use
11/27/2003WO2003059881A3 Dna minor groove binding compounds
11/27/2003WO2003059378A3 Combined use of a glp-1 compound and another drug for treating dyslipidemia
11/27/2003WO2003059270A3 Method for reducing morbidity and mortality in critically ill patients
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003054010A3 Early stage redox-related apoptosis modulator-2 (esram-2)
11/27/2003WO2003054004A3 Secreted proteins
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003052079A3 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
11/27/2003WO2003051901A3 Pseudonucleotide comprising an intercalator
11/27/2003WO2003051383A3 Use of hmgb proteins and nucleic acids that code therefor
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003046176A3 Protein-protein interactions in human immunodeficiency virus
11/27/2003WO2003046150A3 Glycoprotein remodeling using endoglycanases
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042700A3 Breast cancer associated polypeptide
11/27/2003WO2003042344A3 Apo2 ligand/trail formulations
11/27/2003WO2003037932A3 Human coagulation factor vii polypeptides
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003032965A3 Use of ace inhibitors for reducing type 2 diabetes in high risk patients
11/27/2003WO2003032964A3 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
11/27/2003WO2003031651A3 Method of determining susceptibility to inflammatory bowel disease
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003030832A3 Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
11/27/2003WO2003029459A3 Micro-rna molecules
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003028656A3 Adjuvant compositions
11/27/2003WO2003027147A3 Human coagulation factor vii polypeptides
11/27/2003WO2003023011A3 Antisense modulation of ribonuclease l expression
11/27/2003WO2003023005A3 Antisense modulation of pka regulatory subunit rii alpha expression
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003020222A3 PYRROLO[2,3-d]PYRIMIDINES FOR INHIBITING RNA-DEPENDENT RNA VIRAL POLYMERASE
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003018607A3 Process for preparing glycopeptide derivatives
11/27/2003WO2003014144A3 Molecule
11/27/2003WO2003013590A8 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
11/27/2003WO2003010200A3 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006995A3 Method for identifying substances which modulate interleukin 4 (il-4) signaling
11/27/2003WO2003006620A3 Linear and cyclic melanocortin receptor-specific peptides
11/27/2003WO2003006611A3 GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003WO2003003977A3 Compositions and methods for the treatment of body weight disorders, including obesity
11/27/2003WO2003000716A3 Preparation and use of amorphous lisinopril
11/27/2003WO2002099066A3 20 human secreted proteins
11/27/2003WO2002094195A3 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
11/27/2003WO2002092626A3 Cleavage and polyadenylation complex of precursor mrna
11/27/2003WO2002092147A3 Optimization of the molecular properties and formulation of proteins delivered by inhalation
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
11/27/2003WO2002086113A3 Enzyme and snp marker for disease
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003WO2002078730A3 Use of neublastin polypeptides for treating neuropathic pain
11/27/2003WO2002077164A3 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
11/27/2003WO2002077030A3 Modified mhc molecules whose binding to cd8 or cd4 is inhibited and use thereof
11/27/2003WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.
11/27/2003WO2002070647A8 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses
11/27/2003WO2002070019A8 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
11/27/2003WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
11/27/2003WO2002064791A3 Proteins and nucleic acids encoding same
11/27/2003WO2002063010A3 Method of producing recombinant antibodies against tumors
11/27/2003WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
11/27/2003WO2002050113A3 Interleukin-1 related gene and protein
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003WO2002048368A3 Proteins associated with cell growth, differentiation, and death
11/27/2003WO2002048341A3 Knockout mice for a2d2 calcium ion channel subunit proteins
11/27/2003WO2002046424A3 Fibroblast growth factors
11/27/2003WO2000062735A3 Treatment of neoplasms with viruses
11/27/2003US20030221209 Modified proteinase inhibitors
11/27/2003US20030221205 Olfactory and pheromones G-protein coupled receptors
11/27/2003US20030221201 Comprises chimeric transferrin-glucogon like polypeptide with reduced glycosylation, metal binding and receptor recognition for treatment and prevntion of multiple sclerosis, cancer and viral diseases
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220508 An enzyme inhibitor for treating AIDS, viral infections
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220490 Cell membrane directed drugs
11/27/2003US20030220489 29 human secreted proteins
11/27/2003US20030220487 Flea peritrophin nucleic acid molecules, proteins and uses thereof
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders
11/27/2003US20030220482 Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220477 G-protein coupled receptors
11/27/2003US20030220476 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent
11/27/2003US20030220475 Neutralizing immunogenic hev polypepetides
11/27/2003US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein
1 ... 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 ... 3163